Selina Luger, MD, FRCPC; University of Pennsylvania #BtC_ASCO21

18:13

Dr. Selina Luger discusses Biomarkers and their Implications for Therapy in AML.

Acute Myeloid Leukemia

Dr. Selina Luger discusses Biomarkers and their Implications for Therapy in AML.

Acute Myeloid Leukemia Similar Videos

Similar Videos

What’s New in Upfront Treatment of AML?_Joseph Jurcic, MD; #hemeupdates2022

14:44
New directions in the treatment of relapsed and refractory AML_Courtney DiNardo, MD; #BeyondTheCongress

11:13
New Directions in the Treatment of Relapsed and Refractory AML_Gail Roboz, MD; #hemeupdates2022

12:35

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611